Retrovirus in Vaccines Develop Tumors in Humans
In the spring of 1955, Jonas Salk announced that he created a vaccine touted to stop the epidemic of polio that was striking down hundreds of thousands of people around the world. That very same day the government issued a license allowing for the distribution of the vaccine.
Between 1955 and 1963 the polio vaccine was administered to more than 98 million people in the US. By 1959 a researcher at the National Institutes of Health detected a virus in the vaccine that wasn’t supposed to be there: the SV-40. When she extracted this virus and injected it into lab animals, they developed tumors within six months.
The polio vaccine was made by using the kidney tissue of Asian rhesus monkeys. It was believed that when the vaccine was injected into humans, the polio virus would create antibodies against polio. What they didn’t know at the time was that monkey tissue is host to many monkey (simian) viruses. The 40 of the SV-40 means that it was the 40th virus identified in the rhesus monkey tissue.
By 1961 US Public Health Service officials were finding the SV-40 in both the oral and injectable polio vaccines. It took until 1963 before it was decided to stop the SV-40 contaminated polio virus vaccine push in the US and correct the problem.
Several steps were taken. Vaccine makers switched from using Rhesus Monkeys to African Green Monkeys. However, SV-40 has been found in African Green Monkey cells as well. Formalin was added to inactivate the live viruses; however, SV-40 is resistant to formalin. Manufacturers added rabbit anti serum to the seeds from which the vaccines were made to neutralize the SV-40, although no proof was given that this was actually done, plus rabbit tissue is a host of its own viruses.
Regulations were put into effect by the US federal government to control the release of contaminated vaccines. However, vaccines that were manufactured prior to the discovery of the SV-40 were not required to be regulated. Consequently, SV-40 contaminated seeds were used to make polio vaccines for the next 40 years.
In 1988, researchers were starting to detect SV-40 imbedded in a variety of tumors. By 1996 the list of cancers containing SV-40 was on the rise.
Italian researchers were identifying the SV-40 retrovirus in seminal fluids and blood samples in healthy individuals who weren’t subjected to the early contaminated polio vaccines. SV-40 was also found to transmit from mother to child in the womb. (Cancer Research, 1990)
New research being released show that more than 50 % of the monkeys used for vaccines were infected with the simian immune-deficiency virus (SIV). (Vaccines, Neil Z. Miller, 2004)
Japanese researchers based on their findings made recommendations to not use the African Green monkeys for vaccine manufacture. They found that the African Green monkeys tested positive for SIV. (AIDS, 1989)
Minced African Green monkey tissue is still being used today to make live polio vaccines along with newborn calf serum, two antibiotics and formaldehyde. (Medical Economics, 2001) Currently, up to 80 % of the US population born after 1963 is testing positive for the SV-40. (Lancet, vol. 359, Issue 9300 pg 817)